Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Po-Liang Lu

Showing results (311-320 of 322) with videos related to

Pageof 33
Sort By:
International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.
International Journal of Antimicrobial Agents|May 7, 2021
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Hsih-Yeh Tsai, Yu-Lin Lee, Po-Yu Liu, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2020
National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Po-Yu Liu, Yu-Lin Lee, Min-Chi Lu, et al.
Open Forum Infectious Diseases|June 29, 2023
Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter StudyHsin-Yun Sun, Bo-Huang Liou, Tun-Chieh Chen, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010Jien-Wei Liu, Wen-Chien Ko, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010Yen-Hsu Chen, Po-Liang Lu, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010Hsih-Yeh Tsai, Chun-Hsing Liao, Yen-Hsu Chen, et al.
International Journal of Antimicrobial Agents|July 16, 2013
Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010Hsih-Yeh Tsai, Yen-Hsu Chen, Chun-Hsing Liao, et al.
Pageof 33

Showing results (311-320 of 322) with videos related to

Sort By:
Pageof 33
International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.
International Journal of Antimicrobial Agents|May 7, 2021
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Hsih-Yeh Tsai, Yu-Lin Lee, Po-Yu Liu, et al.
Antimicrobial Agents and Chemotherapy|July 22, 2020
National Surveillance of Antimicrobial Susceptibility of Bacteremic Gram-Negative Bacteria with Emphasis on Community-Acquired Resistant Isolates: Report from the 2019 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Po-Yu Liu, Yu-Lin Lee, Min-Chi Lu, et al.
Open Forum Infectious Diseases|June 29, 2023
Optimal Frequency of Hepatitis C Virus (HCV) RNA Testing for Detection of Acute HCV Infection Among At-risk People With Human Immunodeficiency Virus: A Multicenter StudyHsin-Yun Sun, Bo-Huang Liou, Tun-Chieh Chen, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Agreement assessment of tigecycline susceptibilities determined by the disk diffusion and broth microdilution methods among commonly encountered resistant bacterial isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2008 to 2010Jien-Wei Liu, Wen-Chien Ko, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010Yen-Hsu Chen, Po-Liang Lu, Cheng-Hua Huang, et al.
Antimicrobial Agents and Chemotherapy|April 12, 2012
Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010Hsih-Yeh Tsai, Chun-Hsing Liao, Yen-Hsu Chen, et al.
International Journal of Antimicrobial Agents|July 16, 2013
Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010Hsih-Yeh Tsai, Yen-Hsu Chen, Chun-Hsing Liao, et al.
Pageof 33